For the Inventor, By the Inventor

Enter assignee name

Baltimore, MD, United States of America

Nova Pharmaceutical Corporation

USPTO Granted Patents = 23

Trademarks = 1

Forward Citations = 1,428

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Abraham J Domb (12 out of 42 patents)

Waclaw J Rzeszotarski (6 out of 17 patents)

Manoj Maniar (5 out of 8 patents)

4. Ronald M Burch (3 out of 3 patents)

5. Donald J Kyle (3 out of 16 patents)

6. John W Ferkany (2 out of 3 patents)

7. Maria E Guzewska (2 out of 5 patents)

8. Barry G Shearer (2 out of 2 patents)

9. Babu J Mavunkel (2 out of 2 patents)

10. Eyal S Ron (1 out of 35 patents)

11. Michael J Pontecorvo (1 out of 3 patents)

12. Mary E Abreu (1 out of 2 patents)

13. Roger N Hiner (1 out of 5 patents)

14. Richard L Elliott (1 out of 1 patent)

15. Lisa H Conti (1 out of 1 patent)

23 patents: Sort by Forward Citations

1. 5340588 - Liposphere carriers of vaccines (1994-08-23),

2. 5317079 - Fatty acid terminated polyanhydride (1994-05-31),

3. 5270419 - Polyanhydrides of oligomerized unsaturated aliphatic acids (1993-12-14),

4. 5240963 - Branched polyanhydrides (1993-08-31),

5. 5227165 - Liposphere delivery systems for local anesthetics (1993-07-13),

6. 5221535 - Sustained release formulations of insect repellent (1993-06-22),

7. 5189046 - Protein kinase C modulators (1993-02-23),

8. 5188837 - Lipsopheres for controlled delivery of substances (1993-02-23),

9. 5179189 - Fatty acid terminated polyanhydrides (1993-01-12),

10. 5175235 - Branched polyanhydrides (1992-12-29),

11. 5171812 - Polyanhydrides of oligomerized unsaturated aliphatic acids (1992-12-15),

12. 5135917 - Interleukin receptor expression inhibiting antisense oligonucleotides (1992-08-04),

13. 5122367 - Polyanhydride bioerodible controlled release implants for administration (1992-06-16),

14. 5079260 - Method for treating inflammation and compounds and compositions suitable (1992-01-07),

15. 5063245 - Corticotropin-releasing factor antagonism compounds (1991-11-05),

Nova Pharmaceutical Corporation, based in Baltimore, MD, specializes in the development and manufacturing of innovative pharmaceutical products. The company focuses on a range of therapeutic areas, including oncology, neurology, and infectious diseases, aiming to address unmet medical needs through advanced research and technology. With a commitment to quality and efficacy, Nova collaborates with healthcare professionals and institutions to enhance patient outcomes and contribute to the evolving landscape of modern medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

23 Patents

#23 in Baltimore, MD

#189 in Maryland

#14,413 in US

#27,647 in the World

Baltimore, MD, United States of America

Nova Pharmaceutical Corporation

Forward Citations = 1,428

23 inventors:

Abraham J Domb (12 out of 42 patents)

Waclaw J Rzeszotarski (6 out of 17 patents)

Manoj Maniar (5 out of 8 patents)

4. Ronald M Burch (3 out of 3 patents)

5. Donald J Kyle (3 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…